Literature DB >> 6705640

Comparison of effects of nifedipine, propantheline bromide, and the combination on esophageal motor function in normal volunteers.

M Hongo, M Traube, R W McCallum.   

Abstract

Both intracellular calcium ions and neural input are important in esophageal smooth muscle contraction. The aim of this study was to compare the effects of well-tolerated doses of the calcium-channel blocker, nifedipine (20 mg sublingually/buccally) with the anticholinergic, propantheline bromide (15 mg orally) and the combination of these two agents on esophageal motor function. Seven healthy volunteers underwent manometric evaluation after nifedipine, propantheline bromide, the combination, and placebo on different days. Lower esophageal sphincter pressure decreased significantly (P less than 0.05 vs basal and placebo) by 32% after nifedipine, but fell only 21% after propantheline bromide. After the combination lower esophageal sphincter pressure fell by 45% (P less than 0.05 vs basal and placebo and nifedipine alone). Contraction amplitude in the body of the esophagus decreased significantly (P less than 0.05 vs basal and placebo) by 26% after propantheline bromide, but fell only 11% after nifedipine. The combination led to a decrease of 37% in contraction amplitude, but this was not significantly different from that obtained with propantheline bromide alone. No drug or combination had any effect on other manometric parameters. These data show that in the normal subjects studied with the above doses: (1) nifedipine has a greater effect than propantheline bromide on the lower esophageal sphincter; (2) propantheline bromide has a greater effect than nifedipine on esophageal contraction amplitude; and (3) the combination of nifedipine and propantheline bromide has an enhanced effect on both lower esophageal sphincter pressure and esophageal contraction amplitude.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705640     DOI: 10.1007/bf01318513

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  16 in total

1.  High-amplitude peristaltic esophageal contractions associated with chest pain.

Authors:  M Traube; R Albibi; R W McCallum
Journal:  JAMA       Date:  1983-11-18       Impact factor: 56.272

2.  Effect of pirenzepine compared with atropine and L-hyoscyamine on esophageal peristaltic activity in humans.

Authors:  B H Jaup; H Abrahamsson; R Virtanen; E Iisalo
Journal:  Scand J Gastroenterol       Date:  1982-03       Impact factor: 2.423

3.  Nifedipine in the treatment of achalasia.

Authors:  K Berger; R W McCallum
Journal:  Ann Intern Med       Date:  1982-01       Impact factor: 25.391

4.  Differential effect of atropine on rightward and leftward lower esophageal sphincter pressure.

Authors:  B J Richardson; R W Welch
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

5.  Clinical and manometric effects of nifedipine in patients with esophageal achalasia.

Authors:  M Bortolotti; G Labò
Journal:  Gastroenterology       Date:  1981-01       Impact factor: 22.682

6.  Calcium dependence of neuromuscular events in esophageal smooth muscle of the opossum.

Authors:  D J de Carle; J Christensen; A C Szabo; D C Templeman; D R McKinley
Journal:  Am J Physiol       Date:  1977-06

7.  Isosorbide dinitrate and nifedipine treatment of achalasia: a clinical, manometric and radionuclide evaluation.

Authors:  M Gelfond; P Rozen; T Gilat
Journal:  Gastroenterology       Date:  1982-11       Impact factor: 22.682

8.  Effects of nifedipine on esophageal motor function in humans: correlation with plasma nifedipine concentration.

Authors:  M Hongo; M Traube; R G McAllister; R W McCallum
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

9.  Cholinergic effects on esophageal transit and clearance.

Authors:  K Phaosawasdi; L S Malmud; R D Tolin; F Stelzer; G Applegate; R S Fisher
Journal:  Gastroenterology       Date:  1981-11       Impact factor: 22.682

10.  Effect of atropine on esophageal motor function in humans.

Authors:  W J Dodds; J Dent; W J Hogan; R C Arndorfer
Journal:  Am J Physiol       Date:  1981-04
View more
  11 in total

1.  Noncardiac Chest Pain of Esophageal Origin.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1998-12

Review 2.  An overview of the role of calcium antagonists in the treatment of achalasia and diffuse oesophageal spasm.

Authors:  T P Short; E Thomas
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 4.  Current concepts on pathophysiology, diagnosis and treatment of diffuse oesophageal spasm.

Authors:  M Storr; H D Allescher; M Classen
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 5.  Primary oesophageal motility disorders. Current therapeutic concepts.

Authors:  M Traube; R W McCallum
Journal:  Drugs       Date:  1985-07       Impact factor: 9.546

6.  Surgical myotomy in patients with high-amplitude peristaltic esophageal contractions. Manometric and clinical effects.

Authors:  M Traube; V Tummala; A E Baue; R W McCallum
Journal:  Dig Dis Sci       Date:  1987-01       Impact factor: 3.199

Review 7.  Medication-induced oesophageal injury. Survey of the literature.

Authors:  S J Bott; R W McCallum
Journal:  Med Toxicol       Date:  1986 Nov-Dec

8.  Transcutaneous electrical nerve stimulation decreases lower esophageal sphincter pressure in patients with achalasia.

Authors:  M Guelrud; A Rossiter; P F Souney; M Sulbaran
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

9.  Oral pirenzepine does not affect esophageal pressures in man.

Authors:  J N Blackwell; C B Dalton; D O Castell
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

10.  Medical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil, and placebo.

Authors:  G Triadafilopoulos; M Aaronson; S Sackel; R Burakoff
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.